10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership494,762 shares
Latest Disclosed Value $ 10,503,797
UBS Group AG ownership in TXG / 10x Genomics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 494,762 shares of 10x Genomics, Inc. (MX:TXG) valued at $10,503,797 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 861,000 shares of 10x Genomics, Inc.. This represents a change in shares of -42.54% during the quarter.

UBS Group AG has a history of taking positions in derivatives of the underlying security (TXG) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:TXG / 10x Genomics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 494,762 -366,238 -42.54 10,504 -25.20 0.0003
2026-01-29 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 861,000 102,020 13.44 14,043 58.27 0.0023
2025-11-13 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 758,980 -157,997 -17.23 8,872 -16.44 0.0014
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 916,977 84,189 10.11 10,619 46.05 0.0018
2025-05-13 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 832,788 569,261 216.02 7,270 92.12 0.0013
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 263,527 18,773 7.67 3,784 -31.52 0.0007
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 244,754 93,197 61.49 5,527 87.51 0.0012
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 151,557 97,290 179.28 2,948 44.74 0.0007
2024-05-13 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 54,267 48,038 771.20 2,037 485.06 0.0005
2024-02-09 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 6,229 -4,882 -43.94 349 -24.02 0.0001
2023-11-09 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 11,111 1,228 12.43 458 -16.88 0.0002
2023-08-11 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 9,883 -12,589 -56.02 552 -56.03 0.0002
2023-05-12 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 22,472 17,575 358.89 1,254 603.93 0.0005
2023-02-08 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 4,897 3,029 162.15 178 235.85 0.0001
2022-11-10 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 1,868 -1,065 -36.31 53 -59.85 0.0000
2022-08-10 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 2,933 -21,008 -87.75 132 -92.76 0.0001
2022-05-16 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 23,941 -7,150 -23.00 1,822 -60.66 0.0006
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 31,091 2,049 7.06 4,631 9.53 0.0013
2021-11-15 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 29,042 4,245 17.12 4,228 -12.93 0.0013
2021-08-13 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 24,797 -5,530 -18.23 4,856 -11.53 0.0016
2021-05-12 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 30,327 -6,145 -16.85 5,489 6.27 0.0018
2021-02-11 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 36,472 -27,980 -43.41 5,165 -35.73 0.0017
2020-11-12 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 64,452 30,471 89.67 8,036 164.78 0.0030
2020-07-31 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 33,981 5,622 19.82 3,035 71.86 0.0013
2020-05-01 2020-03-31 13F 10X GENOMICS CL A COM 88025U109 28,359 4,160 17.19 1,766 -4.23 0.0008
2020-02-14 2019-12-31 13F 10X GENOMICS CL A COM 88025U109 24,199 23,162 2,233.56 1,844 3,446.15 0.0006
2019-11-14 2019-09-30 13F 10X GENOMICS CL A COM 88025U109 1,037 1,037 52 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F 10X GENOMICS CL A COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-31 2020-06-30 13F 10X GENOMICS CL A COM Call 10,000 893 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.